Biotech

All Articles

Lykos will ask FDA to rethink its selection observing denial of MDMA therapy for post-traumatic stress disorder

.Adhering to an unsatisfactory presenting for Lykos Therapeutics' MDMA prospect for post-traumatic s...

AN 2 fifty percents headcount, stops phase 3 test after records let down

.AN2 Therapeutics is reassessing its business in reaction to uninspired midphase data, promising to ...

Merck pays $700M for bispecific, spying autoimmune opening and also odds to test Amgen in cancer cells

.Merck &amp Co. is actually paying out $700 million in advance to challenge Amgen in a blood cancer ...

Gilead pays out J&ampJ $320M to leave licensing bargain for seladelpar

.Along With Gilead Sciences almost an FDA choice for its own liver condition drug seladelpar, the pr...

' All hands on deck' at Lilly as peers target weight problems market

.CEO David Ricks may observe the business setting up outdoors tents at basecamp responsible for Eli ...

Entero giving up team, vacating workplace and stopping briefly R&ampD

.Cushion Liquidators has actually transformed Entero Rehabs white as a piece. The financial institut...

Exelixis falls ADC after choosing it's no match for Tivdak

.Exelixis is actually quiting on its own cells aspect (TF)- targeting antibody-drug conjugate after ...

Relay loses interest in SHP2 prevention after Genentech leaves behind

.Three full weeks after Roche's Genentech device walked away from an SHP2 prevention deal, Relay The...

Stoke's Dravet disorder med discharged of partial scientific hold

.Stoke Rehabs' Dravet syndrome medication has actually been without a partial grip, getting rid of t...

Fierce Biotech's Gabrielle Masson presents Brutal 15 at NYSE

.Fierce Biotech Affiliate Publisher Gabrielle Masson offered the 2024 training class of Ferocious 15...